Mohammad Asgharzadeh1, Sajjad Pourasghary2, Behrooz Pourasghary3, Manouchehr Nourazarian4, Hossein Samadi Kafil5
1Department of Laboratory Sciences, Faculty of Paramedicine, Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2Department of General Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
3Laboratory Department, Emam Reza Hospital, Tabriz, Iran.
4Department of Laboratory Sciences, Faculty of Paramedicine, Tabriz University of Medical Sciences, Tabriz, Iran.
5Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
DOI: 10.4103/0976-9668.175075

ABSTRACT

Background: Diabetes is the fifth leading cause of death in the world. Hence, we investigated the factors affecting disease control among diabetic patients referred to Imam Reza Hospital (central hospital in the Northwest of Iran). Materials and Methods: One hundred and eight diabetic patients were evaluated. Patient’s main medications including insulin, metformin, glibenclamide, and glytazon were registered and the levels of fasting blood sugar (FBS), glucose 2 h postprandial (pp), and hemoglobin A1c (HbA1c) were measured. All risk factors were evaluated by using a questionnaire completed by the patients. Results: The average of HbA1c, FBS, and glucose 2 h pp was 7.33%, 159 mg/dl, and 233.03 mg/dl, respectively. In patients whose disease was controlled, the family history of the disease, the type of medication, and the visits to family physician had a significant association with disease control. The average mean of HbA1c among patients with controlled and uncontrolled disease was 5.93% and 8.63 % respectively. Conclusion: Less stress, education, and weekly exercise had an essential role in controlling the disease in diabetic patients from the Northwest of Iran and noncompliance with the prescribed diet by the physician and lack of timely medicine intake were the main reasons for uncontrolled disease.

Keywords: Control, diabetes, effective factors, hemoglobin A1c, treatment.

Please follow and like us:
News Reporter